| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,207 |
12,850 |
$640K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,226 |
14,006 |
$605K |
| 80053 |
Comprehensive metabolic panel |
21,287 |
15,957 |
$443K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,671 |
3,547 |
$344K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,315 |
3,160 |
$234K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,736 |
1,474 |
$203K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,935 |
1,629 |
$169K |
| 71045 |
Radiologic examination, chest; single view |
8,820 |
7,012 |
$112K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,617 |
1,466 |
$75K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
801 |
722 |
$70K |
| G0378 |
Hospital observation service, per hour |
3,851 |
2,060 |
$57K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,418 |
3,122 |
$53K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,020 |
1,690 |
$47K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
680 |
573 |
$47K |
| A9270 |
Non-covered item or service |
13,480 |
2,346 |
$40K |
| 71046 |
Radiologic examination, chest; 2 views |
1,739 |
1,489 |
$40K |
| 87040 |
|
2,407 |
1,443 |
$34K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
994 |
744 |
$28K |
| 85027 |
|
25,776 |
18,133 |
$23K |
| 81003 |
|
10,060 |
8,308 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,628 |
1,161 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,451 |
7,838 |
$18K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,789 |
9,572 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
721 |
580 |
$14K |
| 87070 |
|
563 |
505 |
$13K |
| 87400 |
|
1,883 |
1,600 |
$13K |
| 84484 |
|
8,409 |
5,011 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,416 |
2,850 |
$10K |
| 85610 |
|
9,038 |
7,038 |
$10K |
| C1769 |
Guide wire |
161 |
113 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,337 |
2,339 |
$9K |
| 85730 |
|
8,581 |
6,722 |
$7K |
| 83735 |
|
9,626 |
6,617 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
142 |
96 |
$6K |
| 87077 |
|
899 |
740 |
$6K |
| J3490 |
Unclassified drugs |
250 |
154 |
$6K |
| 93975 |
|
334 |
309 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,207 |
1,920 |
$5K |
| 73630 |
|
245 |
219 |
$5K |
| 73610 |
|
226 |
199 |
$5K |
| 73562 |
|
383 |
299 |
$4K |
| 73130 |
|
186 |
163 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
729 |
575 |
$3K |
| 82803 |
|
893 |
692 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,489 |
1,081 |
$3K |
| 87210 |
|
109 |
101 |
$3K |
| 73030 |
|
233 |
168 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,878 |
1,597 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
60 |
50 |
$3K |
| 83880 |
|
2,082 |
1,617 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
541 |
301 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,662 |
2,538 |
$2K |
| 83690 |
|
4,632 |
3,873 |
$2K |
| 36600 |
|
811 |
636 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
385 |
299 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
416 |
155 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
292 |
194 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,329 |
1,026 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,003 |
743 |
$1K |
| 84703 |
|
1,746 |
1,601 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,108 |
1,572 |
$1K |
| 84100 |
|
1,774 |
1,354 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,444 |
3,440 |
$1K |
| 97162 |
|
132 |
102 |
$1K |
| 82550 |
|
1,316 |
1,071 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
262 |
251 |
$1K |
| 81025 |
|
472 |
443 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
318 |
234 |
$1K |
| 84145 |
|
305 |
229 |
$909.88 |
| 80076 |
|
354 |
280 |
$839.74 |
| 85379 |
|
901 |
777 |
$804.68 |
| 73502 |
|
83 |
58 |
$788.03 |
| 00731 |
|
33 |
28 |
$748.73 |
| 86900 |
|
481 |
391 |
$654.17 |
| 97116 |
|
22 |
12 |
$635.75 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
27 |
12 |
$631.42 |
| 84443 |
Thyroid stimulating hormone (TSH) |
585 |
447 |
$625.65 |
| 86901 |
|
482 |
389 |
$612.48 |
| 73110 |
|
45 |
37 |
$604.84 |
| 87186 |
|
493 |
415 |
$599.40 |
| 97161 |
|
120 |
104 |
$596.81 |
| 72110 |
|
151 |
102 |
$590.20 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
390 |
290 |
$544.27 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
365 |
225 |
$520.47 |
| 84702 |
|
259 |
245 |
$487.09 |
| 80061 |
Lipid panel |
406 |
314 |
$484.83 |
| 93971 |
|
83 |
65 |
$471.59 |
| 83605 |
|
1,259 |
978 |
$441.48 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
264 |
253 |
$317.88 |
| 90714 |
|
59 |
41 |
$317.80 |
| 86850 |
|
258 |
208 |
$284.83 |
| J2704 |
Injection, propofol, 10 mg |
335 |
223 |
$274.62 |
| J2060 |
Injection, lorazepam, 2 mg |
76 |
49 |
$262.69 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
141 |
99 |
$223.13 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
473 |
431 |
$193.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
105 |
83 |
$192.32 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
598 |
419 |
$186.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
283 |
225 |
$155.10 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
298 |
194 |
$153.69 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,277 |
942 |
$151.24 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
133 |
105 |
$78.14 |
| 97165 |
|
123 |
102 |
$26.31 |
| 87205 |
|
17 |
12 |
$1.82 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
62 |
60 |
$0.16 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
116 |
84 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
228 |
208 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
38 |
29 |
$0.00 |
| 90715 |
|
18 |
13 |
$0.00 |
| 00811 |
|
24 |
24 |
$0.00 |
| 96376 |
|
713 |
436 |
$0.00 |
| 81001 |
|
46 |
43 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
16 |
13 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
54 |
43 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15 |
12 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
14 |
13 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
50 |
39 |
$0.00 |
| 82270 |
|
14 |
13 |
$0.00 |